Literature DB >> 26603920

International cooperation to improve access to and sustain effectiveness of antimicrobials.

Christine Årdal1, Kevin Outterson2, Steven J Hoffman3, Abdul Ghafur4, Mike Sharland5, Nisha Ranganathan6, Richard Smith7, Anna Zorzet8, Jennifer Cohn9, Didier Pittet10, Nils Daulaire1, Chantal Morel11, Zain Rizvi12, Manica Balasegaram13, Osman A Dar14, David L Heymann15, Alison H Holmes16, Luke S P Moore16, Ramanan Laxminarayan17, Marc Mendelson18, John-Arne Røttingen19.   

Abstract

Securing access to effective antimicrobials is one of the greatest challenges today. Until now, efforts to address this issue have been isolated and uncoordinated, with little focus on sustainable and international solutions. Global collective action is necessary to improve access to life-saving antimicrobials, conserving them, and ensuring continued innovation. Access, conservation, and innovation are beneficial when achieved independently, but much more effective and sustainable if implemented in concert within and across countries. WHO alone will not be able to drive these actions. It will require a multisector response (including the health, agriculture, and veterinary sectors), global coordination, and financing mechanisms with sufficient mandates, authority, resources, and power. Fortunately, securing access to effective antimicrobials has finally gained a place on the global political agenda, and we call on policy makers to develop, endorse, and finance new global institutional arrangements that can ensure robust implementation and bold collective action.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2015        PMID: 26603920     DOI: 10.1016/S0140-6736(15)00470-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  41 in total

1.  Addressing the Unknowns of Antimicrobial Resistance: Quantifying and Mapping the Drivers of Burden.

Authors:  Gwenan M Knight; Ceire Costelloe; Kris A Murray; Julie V Robotham; Rifat Atun; Alison H Holmes
Journal:  Clin Infect Dis       Date:  2018-02-01       Impact factor: 9.079

2.  Threats to global antimicrobial resistance control: Centrally approved and unapproved antibiotic formulations sold in India.

Authors:  Patricia McGettigan; Peter Roderick; Abhay Kadam; Allyson Pollock
Journal:  Br J Clin Pharmacol       Date:  2018-02-21       Impact factor: 4.335

3.  Multicenter Evaluation of the Acuitas AMR Gene Panel for Detection of an Extended Panel of Antimicrobial Resistance Genes among Bacterial Isolates.

Authors:  Patricia J Simner; Kimberlee A Musser; Kara Mitchell; Mark G Wise; Shawna Lewis; Rebecca Yee; Yehudit Bergman; Caryn E Good; Ayman M Abdelhamed; Henry Li; Erin M Laseman; Dan Sahm; Kelsey Pitzer; Julia Quan; G Terrance Walker; Michael R Jacobs; Daniel D Rhoads
Journal:  J Clin Microbiol       Date:  2022-03-16       Impact factor: 11.677

Review 4.  Essential medicines for universal health coverage.

Authors:  Veronika J Wirtz; Hans V Hogerzeil; Andrew L Gray; Maryam Bigdeli; Cornelis P de Joncheere; Margaret A Ewen; Martha Gyansa-Lutterodt; Sun Jing; Vera L Luiza; Regina M Mbindyo; Helene Möller; Corrina Moucheraud; Bernard Pécoul; Lembit Rägo; Arash Rashidian; Dennis Ross-Degnan; Peter N Stephens; Yot Teerawattananon; Ellen F M 't Hoen; Anita K Wagner; Prashant Yadav; Michael R Reich
Journal:  Lancet       Date:  2016-11-08       Impact factor: 79.321

5.  International law's effects on health and its social determinants: protocol for a systematic review, meta-analysis, and meta-regression analysis.

Authors:  Steven J Hoffman; Matthew Hughsam; Harkanwal Randhawa; Lathika Sritharan; Gordon Guyatt; John N Lavis; John-Arne Røttingen
Journal:  Syst Rev       Date:  2016-04-16

Review 6.  Antimicrobial resistance-a threat to the world's sustainable development.

Authors:  Dušan Jasovský; Jasper Littmann; Anna Zorzet; Otto Cars
Journal:  Ups J Med Sci       Date:  2016-07-14       Impact factor: 2.384

7.  An assessment of the future impact of alternative technologies on antibiotics markets.

Authors:  Ejike Nwokoro; Ross Leach; Christine Årdal; Enrico Baraldi; Kellie Ryan; Jens Plahte
Journal:  J Pharm Policy Pract       Date:  2016-10-26

Review 8.  Colistin in Pig Production: Chemistry, Mechanism of Antibacterial Action, Microbial Resistance Emergence, and One Health Perspectives.

Authors:  Mohamed Rhouma; Francis Beaudry; William Thériault; Ann Letellier
Journal:  Front Microbiol       Date:  2016-11-11       Impact factor: 5.640

9.  Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality.

Authors:  Kevin Outterson; Unni Gopinathan; Charles Clift; Anthony D So; Chantal M Morel; John-Arne Røttingen
Journal:  PLoS Med       Date:  2016-06-14       Impact factor: 11.069

10.  Antimicrobial Resistance: Is the World UNprepared?

Authors: 
Journal:  PLoS Med       Date:  2016-09-12       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.